Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Los Angeles | 4,631 Studies Near You

Clinical TrialsLos Angeles

Clinical Trials in Los Angeles

Discover 4,631 clinical trials near Los Angeles, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2141-2160 of 4,631 trials

CompletedComparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal TumorRATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00006734·Birmingham, Alabama and 238 others

Find Trials by Condition in Los Angeles

Breast Cancerin Los Angeles Lung Cancerin Los Angeles Prostate Cancerin Los Angeles Colorectal Cancerin Los Angeles Melanomain Los Angeles Leukemiain Los Angeles Lymphomain Los Angeles Pancreatic Cancerin Los Angeles Ovarian Cancerin Los Angeles Brain Cancerin Los Angeles

Data from ClinicalTrials.govTerms

CompletedSafety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)PSSc-001 (LOTUSS) This study is a Phase 2, multinational, open-label, randomized, parallel-group, safety and tolerability study of pirfenidone in participants with systemic…NCT01933334·Scottsdale, Arizona and 21 others

CompletedLongitudinal Study of Bone Disease in Children with Mucopolysaccharidoses (MPS) I, II, and VIApproximately 85% of individuals with Mucopolysaccharidosis (MPS) type I, II, or VI report weekly pain and 50-60% have significant limitations in their activities of daily living…NCT01521429·Oakland, California and 2 others

Active not recruitingStudy to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 TabletsB-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections.NCT05618028·Los Angeles, California and 38 others

CompletedAdjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast CancerThis was an open label, multi-center protocol for U.S. patients enrolled in the study of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone…NCT03078751·Tucson, Arizona and 32 others

RecruitingTesting the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal CancerThis phase I trial tests the safety, best dose, and effectiveness of ZEN003694 in combination with cetuximab and encorafenib in treating patients with colorectal cancer that has…NCT06102902·Costa Mesa, California and 15 others

TerminatedA Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.NCT05882877·Birmingham, Alabama and 546 others

Active not recruitingNoninterventional Study Evaluating Parkinson's Disease Diary UseThis study aims to evaluate the impact of the frequency of assessments on the variability over time, reliability, and compliance for the Parkinson's disease (PD) diary in patients…NCT05363046·Scottsdale, Arizona and 33 others

RecruitingAnticoagulation in ICH Survivors for Stroke Prevention and RecoveryPrimary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients…NCT03907046·Birmingham, Alabama and 186 others

CompletedN2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk NeuroblastomaRATIONALE: CEP-701 may stop the growth of tumor cells by blocking the enzymes necessary for their growth.NCT00084422·Los Angeles, California and 11 others

Active not recruitingPembrolizumab for the Treatment of Cervical Intraepithelial NeoplasiaThis phase II trial studies the effect of pembrolizumab on cervical intraepithelial neoplasia.NCT04712851·Los Angeles, California

Active not recruitingOsimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain MetastasesThis phase II trial studies how well osimertinib with or without bevacizumab works in treating patients with EGFR positive non-small cell lung cancer that has spread to the brain…NCT02971501·Los Angeles, California and 17 others

RecruitingComparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)This phase II Lung-MAP treatment trial test the combination of targeted drugs (capmatinib, osimertinib, and/or ramucirumab) in treating patients with non-small cell lung cancer…NCT05642572·Daphne, Alabama and 453 others

Active not recruitingS0820, Adenoma and Second Primary Prevention TrialThe investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal…NCT01349881·Birmingham, Alabama and 988 others

CompletedCerebral Hemorrhage Risk in Hereditary Hemorrhagic TelangiectasiaThis study is one of the three projects of an NIH Rare Disease Clinical Research Consortium.NCT01158807·Phoenix, Arizona and 18 others

TerminatedA Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET AmplificationThe purpose of this study was to determine the maximum tolerated dose (MTD) or recommended phase II dose (RP2D) of INC280 in combination with erlotinib in the Phase Ib of this…NCT02468661·Los Angeles, California and 31 others

CompletedHome Walking Exercise Training in Advanced Heart FailureHeart failure is a major public health burden in the United States characterized by increased morbidity and mortality, and reduce exercise capacity with distressing symptoms of…NCT00012883·West Los Angeles, California

CompletedA Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaThis is a Phase 1, open-label, multicenter study evaluating the safety, pharmacokinetic profile, and preliminary efficacy of ABT-199 in combination with Bendamustine/Rituximab in…NCT01594229·La Jolla, California and 7 others

TerminatedOpen-Label Extension of EryDex Study IEDAT-04-2022This is an international, multi-center, prospective, open-label, non-comparative study aiming to provide access to treatment with EryDex to ataxia telangiectasia (A-T) patients…NCT06664853·Los Angeles, California and 20 others

CompletedSelf-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)Insulin therapy requires monitoring and frequent review of glucose levels to optimize dosing. Effective presentation and data analysis are essential.NCT00333853·La Jolla, California and 6 others

PreviousPage 108 of 232Next

Diabetes

in Los Angeles

Heart Diseasein Los Angeles